Strawberry Fields REIT (STRW) Q2 2026 earnings review
Stable Revenues Mask AFFO Contraction Driven by Refinancing Costs
Strawberry Fields REIT delivered stable top-line performance with rental revenues growing 6% YoY to $40.0M and maintaining a perfect 100% rent collection rate. However, bottom-line metrics are reversing. Adjusted Funds From Operations (AFFO) declined from $18.9M to $18.1M YoY, pushing AFFO per share down to $0.32 from $0.34. Management successfully executed a major strategic goal by closing a $300M Corporate Credit Facility (CCF) to fund future acquisitions, but the frictional costs of this move—specifically a 62% YoY spike in G&A and rising interest expenses—are currently cannibalizing cash flow. The company now has the 'dry powder' it desired, placing intense pressure on H2 execution to deploy this capital and meet its $100M-$150M annual acquisition target.
🐂 Bull Case
The closing of the $300M CCF removes previous capital constraints, allowing the company to aggressively pursue its acquisition pipeline without issuing dilutive equity at currently depressed share valuations.
The company maintained 100% contractual rent collection, proving that its strict 10% cap rate underwriting and triple-net master lease model continue to shelter it from operator-level profitability headwinds.
🐻 Bear Case
Despite a 6% revenue increase, AFFO contracted by 4% YoY. Rising overhead and interest expenses tied to recent debt issuances are actively eroding the cash flow needed to self-fund the company's growth engine.
With only a $10.4M campus acquisition announced so far, STRW is heavily dependent on an aggressive wave of Q3 and Q4 closings to meet its stated $100M-$150M annual target.
⚖️ Verdict: ⚪
Neutral. The core portfolio is rock solid and the balance sheet restructuring is complete. However, reversing AFFO per share growth and high frictional closing costs mean management must rapidly deploy the new credit facility into accretive assets to justify the expense.
Key Themes
The $300M 'Dry Powder' Milestone Achieved
Management successfully closed the much-anticipated Corporate Credit Facility ($100M term loan, $200M revolver). Priced at SOFR + 2.75%, this facility replaces restrictive secured bank debt and provides immediate liquidity. This is the primary catalyst to transition the company back into an active acquisition phase for H2 2026.
AFFO Compression Contradicts Positive Narrative
Management's narrative states the company 'continues to do well,' pointing to higher rental revenues. However, AFFO per share is reversing, dropping from $0.34 in 25Q2 to $0.32 in 26Q2. This was directly driven by an accelerating G&A expense profile (+62% YoY, or $1.3M) tied to CCF closing costs, as well as an uptick in interest expenses from new bond issuances. Growth is coming at a steep administrative cost.
Missouri Acquisition Validates Pipeline Execution
STRW entered a contract for a $10.4M hospital campus in Missouri, expected to close in Q3. The deal includes a 60-bed hospital, 99-bed SNF, and medical office buildings. Sized perfectly for their model, it adds $1.04M in initial base rent (exactly a 10% cap rate) with standard 3% annual escalators, showing their underwriting discipline remains intact.
Floating Rate Macro Exposure
The new $300M credit facility ties the company heavily to floating macro rates (SOFR + 2.75%). During the Q1 call, management admitted they had not actively considered fixed-rate swaps, operating under a 'stable-to-declining' rate prognosis. If inflation remains sticky and macro rates do not fall as anticipated, this unhedged floating debt will place a hard ceiling on AFFO growth.
Unyielding SNF 10-Cap Discipline
The company continues to lean into its highly disciplined 'pure-play' SNF strategy. By explicitly refusing to engage in bidding wars with peers like CareTrust for sub-9% cap rate deals, STRW guarantees day-one cash-on-cash accretion for every asset it onboards, protecting its tenant rent coverage baseline (currently healthy at ~2.1x).
Persistent Valuation Disconnect
CEO Moishe Gubin's ongoing frustration with STRW's trading multiple (historically ~9.5x AFFO vs. peer average of ~14x) remains a central theme. Management explicitly stated the new CCF puts the company 'more in line with peers' structurally, hoping this will finally bridge the valuation gap and allow the stock price to gain traction.
Other KPIs
Stable. Up 6% YoY from $37.9M in Q2 2025, driven entirely by accretive acquisitions made over the last 12 months and contractual lease renewals containing built-in escalators.
Stable. Remained relatively flat YoY (up slightly from $8.7M), as higher rental income was almost perfectly offset by the combined increases in interest and administrative expenses.
Stable. Flat YoY. While absolute FFO increased marginally to $20.1M from $20.0M, the per-share value remained static, underscoring that top-line growth is currently just treading water against capital costs.
Guidance
Expected to close in Q3 2026. Will add $1.04 million in annual base rents with 3% annual rent increases, adhering strictly to the company's mandated 10% cap rate yield target.
Stable. Maintained sequentially from Q2 2026, indicating management's commitment to prioritizing retained cash flow for internal acquisitions rather than aggressively hiking the payout ratio.
Key Questions
G&A Expense Run-Rate
General and administrative expenses spiked 62% this quarter due to CCF closing costs. What is the normalized G&A run-rate expected for Q3 and Q4 now that this facility is established?
Floating Rate Debt Hedging
With the $300M CCF tied to SOFR + 2.75%, what specific parameters or rate thresholds would trigger the Board to implement fixed-rate swaps to protect AFFO margins?
H2 Acquisition Confidence
Given the relatively quiet H1 2026 regarding closed deals, what is the current probability-weighted volume of the $325M pipeline expected to physically close by year-end to hit the $100M-$150M target?
Hospital Asset Class Expansion
The upcoming Missouri deal includes a licensed 60-bed hospital and medical office buildings. Should investors view this as a one-off opportunistic 'throw-in', or a tactical expansion of the 'pure-play SNF' model into broader healthcare facilities?